SLC2A1

There are 103 papers on SLC2A1 in aging research: 1 trial and 14 observational studies in people, 62 in animals, 15 in cells, 8 reviews. The newest story, Nov 14, 2026: “Immune-cell traps induce senescence-related changes in eye cells”.

Gene

103 papers study it32 findings

HGNCNCBI GeneTaxon

9 new papers in 30 daysSee all 103 papers on SLC2A1

At a glance

The findings reach people, from one lab or study; independent labs found the same change in mice. 22 independent labs in 12 countries.

“GLUT1 GT and GG genotypes of rs841853 was higher in non‐responders than in responders”
Genetic polymorphisms of GLUT1 (rs841853) and MATE1 (rs2289669) are associated with metformin response in type 2 diabetes mellitusPharmacogenomics2026doi:10.1080/14622416.2026.2752203

1 of its findings points the other way.

Mice: replicated by independent labs. Cells and humans: a single group. Worms or flies: nothing yet.
  • 22 independent labs in 12 countries
  • 1 finding against
  • Funders: National Natural Science Foundation of China and others
  • Human trial1
  • Humans14
  • Animals61
  • Model organisms1
  • Cells15
  • In silico2

Interventions

12

Hypoxia

upin human cells1upin naked mole-rats1

2 studies
  1. Hypoxia increases SLC2A1 in naked mole-rats (glucose uptake capacity in energetically critical organs).

    Animalsglucose uptake capacity in energetically critical organsheart and kidney3% O21 h

  2. Hypoxia increases SLC2A1 in human cells (young CD34+ EPCs).

    Cellsyoung CD34+ EPCsendothelial progenitor cell1% oxygen48 hrs

More on Hypoxia

Metformin

upin human cells1

1 study
  1. Metformin increases SLC2A1 in FN-treated trophoblasts under hypoxia.

    Cellsin FN-treated trophoblasts under hypoxia

More on Metformin

Aerobic exercise

upin mice1

1 study
  1. Aerobic exercise increases SLC2A1 in LPS-induced SAE mice.

    Animalsin LPS-induced SAE micedentate gyrusfour weeks

More on Aerobic exercise

Caloric restriction

upin animals1

1 study
  1. Caloric restriction increases SLC2A1 (4.2-fold).

    Animalsbrain

More on Caloric restriction

Exercise

upin rats1

1 study
  1. Exercise increases SLC2A1 in aging rats.

    Animalsin aging ratsswimming exercisebrain microvesselsmales

More on Exercise

Apocynin

upin mice1

1 study
  1. Apocynin increases SLC2A1 in mice (reproductive aging).

    Animalsreproductive agingdrinking waterplacenta5 mM

More on Apocynin

High glucose

upin mouse cells1

1 study
  1. High glucose increases SLC2A1 in vitro, bone marrow-derived macrophages.

    Cellsin vitro, bone marrow-derived macrophages

More on High glucose

Cafeteria diet-induced developmental obesity

downin rats1

1 study
  1. Cafeteria diet-induced developmental obesity decreases SLC2A1 in rats.

    Animalsheart

More on Cafeteria diet-induced developmental obesity

Vitamin C

no changein mice1

1 study
  1. Vitamin C showed no clear effect on SLC2A1 in mice (vitamin C treatment in old SAM mice).

    Animalsvitamin C treatment in old SAM micekidney

More on Vitamin C

Ketogenic diet

downin rats1

1 study
  1. Ketogenic diet decreases SLC2A1 in rats.

    Animalsprefrontal cortex12 weeks

More on Ketogenic diet

Magnesium oxide

upin humans1

1 study
  1. Magnesium oxide increases SLC2A1 in humans (gestational diabetes) (P = 0.004).

    Human trialgestational diabetesmagnesium oxidePBMCs250 mg/day6 weeksfemalesn = 40

More on Magnesium oxide

All 12

Effects

10

Cognitive function

upin mice2

2 studies
  1. SLC2A1 improves cognitive function in mice (shown by overexpression in LPS-induced SAE mice).

    Animalsshown by overexpression in LPS-induced SAE micehippocampus

  2. SLC2A1 improves cognitive function in mice (1 day after anesthesia/surgery).

    Animals1 day after anesthesia/surgeryhippocampus

Cellular senescence

downin human cells1upin mouse cells1

2 studies
  1. SLC2A1 inhibits cellular senescence in human cells.

    Cells

  2. SLC2A1 increases cellular senescence in mouse cells (overexpression of Glut1).

    Cellsoverexpression of Glut1

More on Cellular senescence

Immunotherapy response

downin humans1

1 study
  1. SLC2A1 is linked with lower immunotherapy response in ESCC patients receiving immunotherapy.

    Humansin ESCC patients receiving immunotherapy

Glucose assimilation

mediatesin Rodentia1

1 study
  1. SLC2A1 mediates glucose assimilation in Rodentia during fasting.

    Animalsduring fastingsmall intestine

Protective effects of physical exercise

is required forin mice1

1 study
  1. SLC2A1 is required for protective effects of physical exercise in mice (shown by knockdown of Slc2a1).

    Animalsshown by knockdown of Slc2a1astrocytes

Amyloid-beta accumulation

downin mice1

1 study
  1. SLC2A1 decreases amyloid-beta accumulation in mice (shown by overexpression in astrocytes).

    Animalsshown by overexpression in astrocytesastrocytes

More on Amyloid-beta accumulation

synaptic plasticity

upin mice1

1 study
  1. SLC2A1 improves synaptic plasticity in mice (1 day after anesthesia/surgery).

    Animals1 day after anesthesia/surgeryhippocampus

glucose metabolism

upin mice1

1 study
  1. SLC2A1 improves glucose metabolism in mice (Conditional GLUT1 overexpression in an abdominal surgery model).

    AnimalsConditional GLUT1 overexpression in an abdominal surgery modelhippocampus

Postoperative cognitive function

upin mice1

1 study
  1. SLC2A1 improves postoperative cognitive function in mice (Conditional GLUT1 overexpression in an abdominal surgery model).

    AnimalsConditional GLUT1 overexpression in an abdominal surgery model

Senescence-associated secretory phenotype (SASP)

upin mouse cells1

1 study
  1. SLC2A1 increases senescence-associated secretory phenotype (SASP) in mouse cells (shown by GLUT1 knockout (GLUT1−/-)).

    Cellsshown by GLUT1 knockout (GLUT1−/-)

More on Senescence-associated secretory phenotype (SASP)

Upstream

6

Reproductive age

downin mice1

1 study
  1. Reproductive age decreases SLC2A1 in mice.

    Animalsplacenta

Maternal age

downin humans1

1 study
  1. Maternal age is linked with lower SLC2A1 in humans.

    Humansplacenta

YAP1

upin human cells1

1 study
  1. YAP1 activates SLC2A1 in human cells (dual luciferase reporter assays).

    Cellsdual luciferase reporter assays

More on YAP1

Diabetes mellitus

upin mice1

1 study
  1. Diabetes mellitus increases SLC2A1 in mice (diabetic mice).

    Animalsdiabetic micegingiva

More on Diabetes mellitus

MIR140

downin human cells1

1 study
  1. MIR140 decreases SLC2A1 in human cells.

    Cells

More on MIR140

Healthy long-living individuals

downin humans1

1 study
  1. Healthy long-living individuals are linked with lower SLC2A1 in humans (healthy vs. frail).

    Humanshealthy vs. frailcirculating mononuclear cells

Associations

1

Metformin nonresponse

upin humans1OR 2.494

1 study
  1. SLC2A1 is associated with metformin nonresponse in humans (Type 2 diabetes mellitus; rs841853 GT and GG genotypes) (GT: OR 2.494, q = 0.071; GG: OR 2.975, q = 0.071; not significant after multiple-testing correction).

    HumansType 2 diabetes mellitus; rs841853 GT and GG genotypesn = 200

Latest

Dec 2025: 2Jan 2026: 4Feb 2026: 2Mar 2026: 5Apr 2026: 2May 2026: 0Jun 2026: 2Jul 2026: 2Aug 2026: 1Sep 2026: 0Oct 2026: 6Nov 2026: 430 papers in 12 months
International Immunopharmacology

Immune-cell traps induce senescence-related changes in eye cells

Experiments in lab-grown human retinal pigment cells found changes associated with senescence, a state in which cells stop dividing.Experiments in lab-grown human retinal pigment cells found changes associated with senescence, a state in which cells stop dividing.

Human cell studyCellular senescence

See all 103 papers on SLC2A1